The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

In other words, right as scientists are on the cusp of an HIV vaccine, their funding gets yanked. Could this be related to the fact that Health and Human Services and Dead Brain Worm Host Robert ...

Fungal infections, particularly in immunocompromised individuals, are responsible for nearly four million deaths annually—however, current treatments are limited and are frequently ineffective. Now, ...

Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 11:20 AM ET. Company Participants. Daniel P. O'Day - Chairman & CEO. Confe ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

Once you’ve been diagnosed with HIV, you’ll start what is known as anti-retroviral therapy (ART). The combination of drugs that you’ll need to take can vary. Still, your choices include non-nucleoside ...

The Trump administration has declared an end to COVID-19 vaccine recommendations for children and pregnant people, and health ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...